Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07810998) titled 'Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Tanta University

Condition: Poly Cystic Ovary Syndrome

Intervention: Drug: Metformin

Recruitment Status: Not recruiting

Phase: Phase 2/Phase 3

Date of First Enrollment: September 10, 2026

Target Sample Size: 60

To know more, visit https://clinicaltrials.gov/study/NCT07810998

Disclaimer: Curated by HT Syndication....